(19)
(11) EP 3 152 565 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.10.2024 Bulletin 2024/41

(45) Mention of the grant of the patent:
28.08.2024 Bulletin 2024/35

(21) Application number: 15803175.7

(22) Date of filing: 01.06.2015
(51) International Patent Classification (IPC): 
G01N 27/327(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 27/3274; G01N 27/3272
(86) International application number:
PCT/US2015/033577
(87) International publication number:
WO 2015/187580 (10.12.2015 Gazette 2015/49)

(54)

ELECTRODE ARRANGEMENTS FOR TEST ELEMENT INTEGRITY

ELEKTRODENANORDNUNGEN FÜR TESTELEMENTINTEGRITÄT

AGENCEMENT D'ÉLECTRODES POUR INTÉGRITÉ D'ÉLÉMENT D'ESSAI

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 05.06.2014 US 201462008160 P

(43) Date of publication of application:
12.04.2017 Bulletin 2017/15

(73) Proprietors:
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)
    Designated Contracting States:
    AL CH CY CZ ES GB GR HR HU IE IS LI MC MK NO PL RO RS SK SM TR 
  • Roche Diabetes Care GmbH
    68305 Mannheim (DE)
    Designated Contracting States:
    AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI 

(72) Inventors:
  • BUCK, Harvey Jr.
    Indianapolis, Indiana 46256 (US)
  • JERNIGAN, Walter
    Carmel, Indiana 46033 (US)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)


(56) References cited: : 
EP-A2- 1 143 245
WO-A2-2012/064645
US-A1- 2005 284 758
US-A1- 2013 140 176
US-A1- 2017 292 930
 WO-A1-2009/076263
US-A1- 2005 284 758
US-A1- 2005 284 773
US-A1- 2013 140 176
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).